arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Ovid Therapeutics Inc.

OVID

$2.59 ▼ -0.16 (-5.82%) at close

12 Visible periods

27 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Ovid Therapeutics Inc. faces fundamental challenges. The fundamentals warrant careful consideration of downside risks.

Market Cap —

Dividend Yield —

Revenue Growth 1181.3% ↗

Op. Margin None

ROIC -32.5% ↗

FCF / Share None

Trailing P/E —

Price / Book 2.6x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Nov 5, 2026.

12-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$7.25M

↑ +1181.3% —

Net Income Profit after all expenses

$-17.41M

↑ +34.1% —

Operating Margin Operating profit as % of sales

-26.6%

↓ -144.6% —

FCF / Share Free cash flow per share

$-0.65

↑ +19.0% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability

Returns

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗
Revenue Growth YoY (%)	1181.3% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+14666%)	-99.7% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1347%)	14726.2% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+183977%)	-99.3% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1341%)	1551.6% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+19295%)	—	—	—	—	—	—	—
EPS Growth YoY (%)	—	—	3.9% Caution Caution Year-over-year change in earnings per share Optimal: > 10%	N/M	N/M	—	—	—	—	—	—	—
Net Income Growth YoY (%)	34.1% Excellent ↑ Excellent Improving Year-over-year change in net income	49.5% Excellent Excellent Year-over-year change in net income	3.4% Caution Caution Year-over-year change in net income	N/M	N/M	-34.0% Weak ↑ Weak Improving Year-over-year change in net income	-16.3% Weak ↑ Weak Improving Year-over-year change in net income	19.8% Good ↑ Good Improving Year-over-year change in net income	-189.1% Weak Weak Year-over-year change in net income	-70.3% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	—	—	19.0% Good Good Year-over-year change in free cash flow	N/M	N/M	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	69.0% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	-86.0% Weak Weak Compound annual revenue growth over 3 years	160.4% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—
Revenue CAGR 5Y (%)	-10.5% Weak Weak Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗
Operating Margin (%) (%)	—	—	-26.6% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-277%)	—	59.6% Excellent Excellent Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+297%)	—	—	—	—	—	—	—
Effective Tax Rate (%) (%)	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	1.1% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—
Profit Margin (%) (%)	-240.1% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2101%)	—	-23.5% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-296%)	—	58.9% Excellent Excellent Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+391%)	—	—	—	—	—	—	—
FCF Margin (%) (%)	—	—	-20.6% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	—	56.8% Excellent Excellent Free cash flow as a percentage of revenue Optimal: > 10%	-409.8% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—
FCF / Net Income (x)	2.20x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	2.12x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.88x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	1.04x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.96x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.64x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.85x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.88x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.49x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗
Return on Invested Capital (%)	-32.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-90.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-67.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-42.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	68.4% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-186.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-69.3% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-107.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-61.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-36.1% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-15.3% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-28.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-67.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-41.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-35.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	63.8% Excellent ↑ Excellent Improving Operating profit relative to total assets Optimal: > 10%	-107.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-76.0% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-111.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-72.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	-42.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	-13.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-189%)	-38.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-358%)	-59.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-497%)	-41.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-373%)	68.3% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+356%)	-185.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1338%)	-86.3% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-676%)	-134.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-993%)	-77.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-618%)	-45.5% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-403%)	-19.3% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-229%)	—

⚖️ Is the balance sheet risky? 1 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗
Net Debt (USD)	$-13.15M	$-26.30M	$-27.04M	$-44.87M	$-187.80M	$-72.03M	$-41.90M	$-36.49M	$-87.13M	$-51.94M	$-69.94M	$-4.85M

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗
Revenue per Share (USD)	—	—	$3.16	$0.02	$3.09	$0.22	—	—	—	—	—	—
Basic EPS, GAAP (USD)	—	—	$-0.74	$-0.77	$1.78	$-1.39	—	—	—	—	—	—
Free Cash Flow per Share (USD)	—	—	$-0.65	$-0.80	$1.76	$-0.88	—	—	—	—	—	—
Book Value per Share (USD)	$1.00	$0.96	$1.24	$1.88	$2.55	$0.66	$1.28	$1.57	$3.39	$5.01	—	—
Tangible Book Value per Share (USD)	$1.00	$0.96	$1.24	$1.88	$2.55	$0.66	$1.28	$1.57	$3.39	$5.01	—	—
Basic Weighted Avg Shares (shares)	—	—	70.58M	70.42M	67.48M	58.45M	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗
Working Capital (USD)	$66.08M	$45.42M	$98.12M	$124.39M	$175.68M	$52.78M	$69.28M	$35.42M	$82.57M	$48.68M	—	—
Total Equity (USD)	$130.66M	$68.23M	$87.80M	$132.27M	$179.75M	$43.63M	$70.02M	$38.81M	$83.44M	$49.29M	$68.07M	$4.74M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗
Sales/Revenue/Turnover (USD)	$7.25M	$566.00K	$222.80M	$1.50M	$208.38M	$12.62M	—	—	—	—	—	—
Depreciation Expense (USD)	$273.00K	$613.00K	$568.28K	$512.50K	$237.08K	$306.85K	$255.00K	$141.73K	$80.31K	$56.51K	$11.78K	—
Net Income, GAAP (USD)	$-17.41M	$-26.43M	$-52.34M	$-54.17M	$122.83M	$-81.04M	$-60.46M	$-51.98M	$-64.81M	$-22.41M	$-13.16M	—
Operating Cash Flow (USD)	$-38.33M	$-55.96M	$-45.78M	$-55.23M	$118.61M	$-51.58M	$-51.09M	$-45.56M	$-31.47M	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 12 years · 44 quarters

Ovid Therapeutics Inc.

Analytical Summary

12-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare OVID with peers